Katerina S.

Katerina S. currently serves as a Senior Medical Science Liaison and Associate Director at Takeda Oncology, focusing on solid tumors as the molecule lead for Fruquintinib. Previously at HUTCHMED, Katerina held the role of Principal Medical Science Liaison in Oncology and Hematology, contributing to the advancement of therapies for both solid tumors and hematologic malignancies. Experience also includes positions at Taiho Oncology, where responsibilities involved fostering relationships with key opinion leaders, and MD Anderson Cancer Center, where project management and coordination of clinical trials were emphasized. Katerina's earlier career featured roles in business development at PsychoGenics and External Pharma and scientific leadership at Lexicon Pharmaceuticals. Academic credentials include a PhD in Pharmacology and Toxicology and additional qualifications in Neuroscience and Biology from prestigious institutions.